top of page
The Sound of Evolution
Exenatide
Mechanism of action:
Exenatide is a glucagon-like peptide-1 receptor agonist. By binding to GLP-1 receptors on pancreatic β cells, Exenatide promotes glucose-dependent insulin secretion while simultaneously suppressing glucagon release, delaying gastric emptying, and influencing central appetite regulation pathways. Together, these effects shift glucose-regulatory signaling toward lower blood glucose levels.
Reference(s):
1. Gao W et al. (2012). Target-mediated pharmacokinetic and pharmacodynamic model of exendin-4 in rats, monkeys, and humans. Drug Metab Dispos.
2. Copley K et al. (2006). Investigation of exenatide elimination and its in vivo and in vitro degradation. Curr Drug Metab.
bottom of page